指南与共识老年与多病共存慢病管理

老年人肾功能下降时处方推荐应用不足:全科实践横断面研究

Application of prescribing recommendations in older people with reduced kidney function: a cross-sectional study in general practice.
指南 / 共识 · Br J Gen Pract · 2018-04-23

结果显示,4-40%的≥65岁患者及24-80%的≥85岁患者肾功能过低而不适合推荐处方,且eGFR会高估肾功能,导致处方风险。

要点

  • ≥65岁患者中4-40%肾功能过低而不适合推荐处方,≥85岁达24-80%。
  • eGFR高估肾功能:≥65岁中3-28%,≥85岁中13-58%。
  • 肾功能下降时处方应使用Cockcroft-Gault肌酐清除率而非eGFR。

核心结论

  • 肾功能下降时推荐的处方标准未能在许多≥65岁初级保健患者中落实。
  • 使用eGFR会显著高估肾功能,处方时应评估Cockcroft-Gault肌酐清除率。

研究设计与样本

  • 分析8种示例药物在肾功能下降时处方超出推荐的发生率。
  • 收集年龄、性别、实际体重、血清肌酐和eGFR,并用实际体重和估计理想体重计算Cockcroft-Gault肌酐清除率。

主要发现

  • ≥65岁患者中4-40%肾功能过低而不适合推荐处方,≥85岁患者中为24-80%。
  • 超过90%的患者有近期记录的肾功能结果。
  • 使用eGFR替代肌酐清除率时,≥65岁患者中3-28%肾功能被高估,≥85岁患者中为13-58%。
  • 年龄增加预测肾功能估计值过低而不适合推荐处方的 odds 更高。

关键数值与推荐

  • ≥65岁患者中4-40%肾功能过低而不适合8种示例药物的推荐处方。
  • ≥85岁患者中24-80%肾功能过低而不适合推荐处方。
  • eGFR高估肾功能的比例在≥65岁为3-28%,在≥85岁为13-58%。

临床怎么用

  • 为≥65岁肾功能下降患者处方时,应使用Cockcroft-Gault肌酐清除率评估肾功能,而非仅依赖eGFR。
  • 需采取措施帮助处方者在肾功能下降时遵循推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Kidney function reduces with age, increasing the risk of harm from increased blood levels of many medicines. Although estimated glomerular filtration rate (eGFR) is reported for prescribing decisions in those aged ≥65 years, creatinine clearance (Cockcroft-Gault) gives a more accurate estimate of kidney function. AIM: To explore the extent of prescribing outside recommendations for people aged ≥65 years with reduced kidney function in primary care and to assess the impact of using eGFR instead of creatinine clearance to calculate kidney function. DESIGN AND SETTING: A cross-sectional survey of anonymised prescribing data in people aged ≥65 years from all 80 general practices (70 900 patients) in a north of England former primary care trust. METHOD: The prevalence of prescribing outside recommendations was analysed for eight exemplar drugs. Data were collected for age, sex, actual weight, serum creatinine, and eGFR. Kidney function as creatinine clearance (Cockcroft-Gault) was calculated using actual body weight and estimated ideal body weight. RESULTS: Kidney function was too low for recommended prescribing in 4-40% of people aged ≥65 years, and in 24-80% of people aged ≥85 years despite more than 90% of patients having recent recorded kidney function results. Using eGFR overestimated kidney function for 3-28% of those aged ≥65 years, and for 13-58% of those aged ≥85 years. Increased age predicted higher odds of having a kidney function estimate too low for recommended prescribing of the study drugs. CONCLUSION: Prescribing recommendations when kidney function is reduced are not applied for many people aged ≥65 years in primary care. Using eGFR considerably overestimates kidney function for prescribing and, therefore, creatinine clearance (Cockcroft-Gault) should be assessed when prescribing for these people. Interventions are needed to aid prescribers when kidney function is reduced.

来源:Br J Gen Pract,查看原文。版权归原作者所有。

引用

  1. Wood S, Petty D, Glidewell L, et al. Application of prescribing recommendations in older people with reduced kidney function: a cross-sectional study in general practice. Br J Gen Pract. 2018. PMID: 29686132. doi:10.3399/bjgp18X695993

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。